Yoko Aoi
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Deputy Review Director, Office of New Drug V
Dr. Yoko Aoi is a deputy review director of Office of New Drug V responsible for review and scientific advice on oncology drugs. After joining PMDA, Dr. Aoi was involved in review and scientific advice on new drugs for rheumatoid arthritis, asthma, COPD etc. (2011-2016) and planning and coordinating international activities such as PMDA Asia Training Center (2016-2019). In addition, Dr. Aoi is leading Orphan drugs WG which investigates problems in development and application review, and proposes support measures in order to contribute to the orphan drug development. Moreover, Dr. Aoi was involved in ICH E17 EWG/IWG as Deputy Topic Leader from 2014 to 2020. Dr. Aoi holds a PhD from Tokyo Dental and Medical University.
or sign up with email →
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
